Physician profile
Bernadette Schmidt
NPI 1659935641
$3,089.22
in general payments reported to CMS, 2019-2025
18 companies · $36.85 in 2025
The $36.85 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $279 · 2022: $1,069 · 2023: $935 · 2024: $770 · 2025: $36.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $905.90 | 2022-2023 | Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $812.87 | 2021-2024 | Breztri, Tezspire, Airsupra |
| E.R. Squibb & Sons, L.L.C. | $201.52 | 2021-2022 | |
| Inari Medical, INC. | $178.89 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $175.73 | 2021-2024 | Dupixent |
| Gilead Sciences, INC. | $133.55 | 2022-2023 | |
| Genzyme Corporation | $130.53 | 2023 | |
| Axsome Therapeutics, INC. | $124.31 | 2023 | Sunosi |
| Inspire Medical Systems, INC. | $110.94 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $109.62 | 2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.39 | 2022-2023 | Ofev |
| Jazz Pharmaceuticals INC. | $36.85 | 2025 | |
| Harmony Biosciences LLC | $27.49 | 2022 | |
| Edwards Lifesciences Corporation | $25.51 | 2024 | Hemosphere |
| Pfizer INC. | $21.89 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $18.35 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.76 | 2023 | Glassia |
| Insmed, INC. | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernadette Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.